S
Sagimet Biosciences (SGMT)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Sagimet Biosciences (SGMT)
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of several diseases that result from ... Read more
- USD8.60
- USD8.81
- USD7.98
- USD11.41
- 2.70%
- --
- 826.89k
- 1.02M
- 314M
- 1.73
- 137.10%
Stock News
25 minutes ago
Trump’s firing of BLS commissioner decried as ‘groundless’ and ‘giving way to authoritarianism’
MarketWatch
4 hours ago
'The revisions are hard evidence': White House struggles to justify firing of BLS chief over weak jobs numbers
CNBC
6 hours ago
Divorce attorneys share 2 ways to protect your money in a rocky marriage
CNBC
6 hours ago
The top 10 U.S. cities for job opportunities and earning potential, according to new report—New York and LA don't make the list
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
